| Application no. and date | 09159138.8 (espacenet) (Federated) (European Patent Register), 20011219 | | Patent/reg. no. and date | DK/EP 2311825, 20151007 | | Publication date | 20110420 | | Priority no. and date | US 257526 P, 20001221, US 262403 P, 20010116 | | EP pub. no. and date |
EP 2311825 20110420 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V135246DK | | Inventor | BOLOOR, Amogh, 2302 17th Street, 10
Lubbock, TX 79401, US,
Cheung, Mui, GlaxoSmithKline
Five Moore Drive PO Box 13398
Research Triangle Park, NC 27709, US,
Davis, Ronda, GlaxoSmithKline
Five Moore Drive PO Box 13398
Research Triangle Park, NC 27709, US,
Harris, Philip Anthony, GlaxoSmithKline
Five Moore Drive PO Box 13398
Research Triangle Park, NC 27709, US,
Hinkle, Kevin, GlaxoSmithKline
Five Moore Drive PO Box 13398
Research Triangle Park, NC 27709, US,
Mook, Robert Anthony Jr, GlaxoSmithKline
Five Moore Drive PO Box 13398
Research Triangle Park, NC 27709, US,
Stafford, Jeffery Alan, GlaxoSmithKline
Five Moore Drive PO Box 13398
Research Triangle Park, NC 27709, US,
Veal, James Martin, GlaxoSmithKline
Five Moore Drive PO Box 13398
Research Triangle Park, NC 27709, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61K 31/53 (2006.01) , A61P 35/00 (2006.01) , C07D 231/56 (2006.01) , C07D 235/08 (2006.01) , C07D 239/30 (2006.01) , C07D 403/12 (2006.01) , C07D 413/14 (2006.01) | | Title | PYRIMIDINAMINER SOM ANGIOGENESEMODULATORER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
